121 related articles for article (PubMed ID: 34585821)
1. Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: A cohort study.
Coppola C; Masarone M; Bartoli M; Staiano L; Coppola R; Torre P; Conforti M; Amoruso D; Gardini I; Persico M
J Viral Hepat; 2022 Feb; 29(2):171-173. PubMed ID: 34585821
[No Abstract] [Full Text] [Related]
2. Detecting HCV infection by means of mass population SARS-CoV-2 screening: A pilot experience in Northern Italy.
Giacomelli A; Pagani G; Conti F; Bassoli C; Galli M
J Hepatol; 2021 Aug; 75(2):484-486. PubMed ID: 33453329
[No Abstract] [Full Text] [Related]
3. Hepatitis C screening during SARS-CoV-2 testing or vaccination. Experience in an area of southern Italy in the province of Salerno.
Torre P; Annunziata M; Sciorio R; Coppola C; Masarone M; Persico M
Liver Int; 2022 Jun; 42(6):1467-1469. PubMed ID: 35395130
[No Abstract] [Full Text] [Related]
4. HCV point of care screening in people tested for SARS-CoV-2 in a social-housing neighbourhood of Milan, Italy.
Beltrami M; Pagani G; Conti F; Pezzati L; Casalini G; Rondanin R; Prina A; Zagari A; Galli M; Giacomelli A
Liver Int; 2023 Jan; 43(1):251-255. PubMed ID: 35869660
[No Abstract] [Full Text] [Related]
5. Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world.
Crespo J; Lazarus JV; Iruzubieta P; García F; García-Samaniego J;
J Hepatol; 2021 Jul; 75(1):224-226. PubMed ID: 33757805
[No Abstract] [Full Text] [Related]
6. HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination?
Crespo J; Díaz-González Á; Cabezas J
J Hepatol; 2021 Aug; 75(2):486-487. PubMed ID: 33971225
[No Abstract] [Full Text] [Related]
7. Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy.
Piselli P; Serraino D; Fusco M; Girardi E; Pirozzi A; Toffolutti F; Cimaglia C; Taborelli M;
BMC Infect Dis; 2021 Jul; 21(1):667. PubMed ID: 34238231
[TBL] [Abstract][Full Text] [Related]
8. Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking.
Elghoneimy LK; Ismail MI; Boeckler FM; Azzazy HME; Ibrahim TM
Comput Biol Med; 2021 Jul; 134():104468. PubMed ID: 34015671
[TBL] [Abstract][Full Text] [Related]
9. Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?
do Carmo RF; de Souza CDF
J Hepatol; 2022 Feb; 76(2):470-472. PubMed ID: 34437907
[No Abstract] [Full Text] [Related]
10. Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades.
Morisco F; Loperto I; Stroffolini T; Lombardo FL; Cossiga V; Guarino M; De Feo A; Caporaso N
J Med Virol; 2017 Feb; 89(2):291-297. PubMed ID: 27431017
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center.
Berger JM; Gansterer M; Trutschnig W; Bathke AC; Strassl R; Lamm W; Raderer M; Preusser M; Berghoff AS
Wien Klin Wochenschr; 2021 Sep; 133(17-18):909-914. PubMed ID: 34410467
[TBL] [Abstract][Full Text] [Related]
12. Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP).
Zama D; Baccelli F; Colombini A; Contino A; Calore E; Petris MG; Meneghello L; Mercolini F; Lo Vecchio A; Montalto S; Meazza C; Barone A; Compagno F; Muggeo P; Soncini E; Brescia L; Giraldi E; Giurici N; Mura RM; Cellini M; Perruccio K; Petroni V; La Spina M; Ziino O; Burnelli R; De Santis R; Mascarin M; Barretta V; Tridello G; Cesaro S
Ann Hematol; 2022 Aug; 101(8):1843-1851. PubMed ID: 35726104
[TBL] [Abstract][Full Text] [Related]
13. Kidney transplant rejection rate in screened patients for anti-SARS-CoV-2 antibodies, during COVID-19 pandemic in Northern Italy.
Asti AL; Lilleri D; Gregorini M; Zelini P; Pattonieri EF; Sepe V; Libetta C; Islami T; Baldanti F; Rampino T
New Microbiol; 2021 Jul; 44(3):184-186. PubMed ID: 34783351
[TBL] [Abstract][Full Text] [Related]
14. Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions.
Rosato V; Kondili LA; Nevola R; Perillo P; Mastrocinque D; Aghemo A; Claar E
Viruses; 2022 May; 14(5):. PubMed ID: 35632837
[No Abstract] [Full Text] [Related]
15. Mortality is not increased in SARS-CoV-2 infected persons with hepatitis C virus infection.
Butt AA; Yan P; Chotani RA; Shaikh OS
Liver Int; 2021 Aug; 41(8):1824-1831. PubMed ID: 33534931
[TBL] [Abstract][Full Text] [Related]
16. Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic.
Calò F; Di Fraia A; Russo A; Di Biase A; Misso S; Coppola N
Blood Transfus; 2022 May; 20(3):263-264. PubMed ID: 34694221
[No Abstract] [Full Text] [Related]
17. Is elimination of HCV in 2030 realistic in Central Europe.
Flisiak R; Zarębska-Michaluk D; Frankova S; Grgurevic I; Hunyady B; Jarcuska P; Kupčinskas L; Makara M; Simonova M; Sperl J; Tolmane I; Vince A
Liver Int; 2021 Jun; 41 Suppl 1():56-60. PubMed ID: 34155796
[TBL] [Abstract][Full Text] [Related]
18. The impact of the first, second and third waves of covid-19 on hepatitis B and C testing in Ontario, Canada.
Mandel E; Peci A; Cronin K; Capraru CI; Shah H; Janssen HLA; Tran V; Biondi MJ; Feld JJ
J Viral Hepat; 2022 Mar; 29(3):205-208. PubMed ID: 34820967
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of HCV infection in the general population: a survey in a southern Italian town.
Cozzolongo R; Osella AR; Elba S; Petruzzi J; Buongiorno G; Giannuzzi V; Leone G; Bonfiglio C; Lanzilotta E; Manghisi OG; Leandro G; ; Donnaloia R; Fanelli V; Mirizzi F; Parziale L; Crupi G; Detomaso P; Labbate A; Zizzari S; Depalma M; Polignano A; Lopinto D; Daprile G
Am J Gastroenterol; 2009 Nov; 104(11):2740-6. PubMed ID: 19638964
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.
Esposito S; Neglia C; Affanni P; Colucci ME; Argentiero A; Veronesi L; Messina G; Deolmi M; Principi N;
Front Public Health; 2021; 9():628098. PubMed ID: 34249830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
